It can slow down the progression of IDD, promote the expressions of TIMP-3, TGF-β, and COL2A1, and inhibit the inflammatory response of cytokines TNF-α, IL-1β, IL-6, and IL-17 via downregulating their expression levels. The gene discussed is IL17A; the disease is intervertebral disk degenerative disorder.